Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Hims & Hers Health, Inc. Class A Common Stock
(NY:
HIMS
)
39.20
-0.82 (-2.05%)
Official Closing Price
Updated: 7:00 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hims & Hers Health, Inc. Class A Common Stock
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
48
49
Next >
Stocks Brush Off Global Trade Tensions, PPI Data
↗
February 13, 2025
Stocks are firmly higher today, despite rising global trade tensions and another hotter-than-expected inflation reading.
Via
Talk Markets
Topics
Economy
Stocks / Equities
World Trade
Robinhood, Gilead Sciences, Crocs, Lincoln Electric, HubSpot, GE HealthCare And Other Big Stocks Moving Higher On Thursday
↗
February 13, 2025
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
February 12, 2025
Via
Benzinga
Why Hims & Hers Terrifies Big Pharma
↗
February 12, 2025
Big pharma tried to stop Hims & Hers' Super Bowl ad.
Via
The Motley Fool
Hims & Hers Health Unusual Options Activity For February 10
↗
February 10, 2025
Via
Benzinga
Hims & Hers Health Unusual Options Activity
↗
February 07, 2025
Via
Benzinga
Hims & Hers Health Unusual Options Activity For February 03
↗
February 03, 2025
Via
Benzinga
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends
February 12, 2025
GLP-1 weight loss drugs are in short supply enabling lab to make compounded GLP-1 treatments sold for 80% less than the name-brand drugs.
Via
MarketBeat
Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today
↗
February 10, 2025
Via
The Motley Fool
Hims & Hers Takes Aim At Big Pharma In Controversial Super Bowl Ad — Retail Loves The Fight
↗
February 10, 2025
The commercial aired Sunday night on Fox and positioned obesity as "America's deadliest epidemic" while criticizing the $160 billion weight-loss industry and the broader healthcare system.
Via
Stocktwits
US Stocks To Open On A Positive Note After A String Of Bad Mondays: Recent Dip Has 'Reached Its Low Point,' Says Technical Analyst
↗
February 10, 2025
U.S. stock futures rose on Monday following Friday's sharp fall as investors digest tariff updates and earnings reports.
Via
Benzinga
Topics
World Trade
Unlocking the Growth Potential of NYSE:HIMS.
↗
January 31, 2025
A fundamental analysis of (NYSE:HIMS): Is HIMS & HERS HEALTH INC (NYSE:HIMS) suited for growth investing?
Via
Chartmill
Is Hims & Hers Health Stock a Buy?
↗
January 28, 2025
Here's a look into one of healthcare's hottest growth stocks.
Via
The Motley Fool
Super Bowl Commercials 2025: Complete List of Super Bowl LIX Ads And Companies Behind Them
↗
February 10, 2025
The list of Super Bowl LIX commercials and the companies behind the Super Bowl ads.
Via
Benzinga
IBD 50 Stock Hims & Hers Faces Backlash Over Provocative Super Bowl Ad
↗
February 07, 2025
Shares rocketed on Friday, but the company might not be out of hot water yet.
Via
Investor's Business Daily
EXCLUSIVE: Is Super Bowl $7M Ad Cost Worth It? 61% Say No, 18% Say They Looked Up Companies After Last Year's NFL Championship
↗
February 07, 2025
Benzinga readers pick whether a $7 million Super Bowl cost is worth it for companies and how likely they are to look up a company that may be new to them after the big game.
Via
Benzinga
Hims & Hers Health Unusual Options Activity
↗
January 21, 2025
Via
Benzinga
Why the high growth investor may take a look at NYSE:HIMS.
↗
January 20, 2025
Unlocking the high Growth Potential of HIMS & HERS HEALTH INC (NYSE:HIMS).
Via
Chartmill
Super Bowl LIX Commercials: AI, Celebs, Muppets, Warren Buffett-Linked Brand Take The Spotlight
↗
February 07, 2025
A list of Super Bowl LIX commercials and the celebrities and athletes attached to star in the ads.
Via
Benzinga
Topics
Artificial Intelligence
We Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug Wars
↗
February 07, 2025
Lilly’s fiercest competitor in the obesity market is Novo Nordisk, which offers Ozempic and Wegovy. However, rising threats from other players such as Hims & Hers, Amgen, and Viking Therapeutics also...
Via
Stocktwits
Hims & Hers Launches Health Collective and Community Member Council
February 04, 2025
From
Hims & Hers
Via
Business Wire
Is Hims & Hers Stock in Trouble?
↗
January 16, 2025
Via
The Motley Fool
Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
February 03, 2025
From
Hims & Hers
Via
Business Wire
Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?
↗
February 02, 2025
Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following positive clinical trial results and other companies like Surgery Partners...
Via
Benzinga
Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play
January 22, 2025
GLP-1 drugs have been all the rage for weight loss, but GE Healthcare and Novo Nordisk are working on a non-invasive approach to controlling metabolic functions
Via
MarketBeat
8 Health Care Stocks Whale Activity In Today's Session
↗
January 20, 2025
Via
Benzinga
Hims & Hers Health: A Stock to Trade or Own?
January 20, 2025
HIMS achieved remarkable growth in 2024 but now faces challenges in 2025, raising the question of whether it suits traders better than long-term investors.
Via
MarketBeat
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today
↗
January 17, 2025
Via
The Motley Fool
Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value
January 17, 2025
Here are three low-priced stocks you can buy today that are positioned in sector that make them solid choices to double in 2025
Via
MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session
↗
January 14, 2025
Via
Benzinga
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
48
49
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
